Key Insights

Highlights

Treatment Research

3 treatments under study, led by Plateletrich Plasma Combined With Hyaluronic Acid

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06290219Phase 3UnknownPrimary

The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction

Showing all 1 trials

Research Network

Common Treatments

  • Plateletrich Plasma Combined With Hyaluronic Acid1
  • Zinc Gluconate 10 Mg Oral Tablet1
  • 4 Bottles Of Phenyl Ethyl Alcohol Lemon Eucalyptus And Clove Oil1

Active Sponsors

  • Taichung Veterans General Hospital1

Top Investigators

Related Conditions

  • Effect Of Drug1

Activity Timeline